Prostate cancer treatment strategies are guided by risk-stratification. This stratification can be difficult in some patients with known comorbidities. New models are needed to guide strategies and determine which patients are at risk of prostate cancer mortality. This article presents a gradient-boosting model to predict the risk of prostate cancer mortality within 10 years after a cancer diagnosis, and to provide an interpretable prediction. This work uses prospective data from the PLCO Cancer Screening and selected patients who were diagnosed with prostate cancer. During follow-up, 8776 patients were diagnosed with prostate cancer. The dataset was randomly split into a training ( = 7021) and testing ( = 1755) dataset. Accuracy was 0.98 (±0.01), and the area under the receiver operating characteristic was 0.80 (±0.04). This model can be used to support informed decision-making in prostate cancer treatment. AI interpretability provides a novel understanding of the predictions to the users.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234681PMC
http://dx.doi.org/10.3390/cancers13123064DOI Listing

Publication Analysis

Top Keywords

prostate cancer
28
cancer mortality
12
cancer
9
model predict
8
cancer treatment
8
risk prostate
8
patients diagnosed
8
diagnosed prostate
8
prostate
7
development validation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!